心臟人工智慧監測和診斷市場—全球產業規模、佔有率、趨勢、機會和預測，按產品、按類型、按應用、按最終用戶、按地區和競爭細分，2020-2030 年

2024 年全球心臟人工智慧監測和診斷市場價值為 12.4 億美元，預計到 2030 年將達到 21.1 億美元，複合年成長率為 9.42%。這個市場正在經歷快速發展，推動力來自心血管疾病負擔的增加和對先進診斷技術日益成長的需求。人工智慧 (AI) 擴大被融入心臟護理中，透過對心電圖、心臟成像和生物標記資料的高級分析，能夠在早期準確地檢測出心臟疾病。這些 AI 工具支持早期干預，減少診斷錯誤，並改善患者預後。隨著遠端監控和遠距醫療的普及，人工智慧穿戴裝置變得越來越普遍，可以提供對心臟健康的即時洞察和個人化護理。雲端基礎設施、資料整合能力和持續學習演算法的擴展進一步推動了整個生態系統的創新。市場預計將強勁成長，醫療保健提供者和科技公司正在合作提供可擴展、精確和可訪問的心臟診斷。

關鍵市場促進因素

心血管疾病發生率上升

主要市場挑戰

數據可用性和品質

主要市場趨勢

穿戴式裝置和遠端監控的興起

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球心臟人工智慧監測與診斷市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按產品（軟體、硬體）
  • 按類型（心臟診斷{影像學、心電圖診斷、其他診斷}、心臟監測）
  • 依應用（缺血性心臟病/冠狀動脈疾病、心律不整、缺血性中風、其他）
  • 按最終使用者（醫院、診斷中心、其他）
  • 按公司分類（2024）
  • 按地區
• 市場地圖

第6章：北美心臟人工智慧監測與診斷市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第7章：歐洲心臟人工智慧監測與診斷市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太心臟人工智慧監測與診斷市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲

第9章：南美洲心臟人工智慧監測與診斷市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東和非洲心臟人工智慧監測和診斷市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 產品發布
• 併購

第 13 章： 大環境分析

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章：競爭格局

• AliveCor Inc.
• Aidoc
• Boston Scientific Corporation
• Canon Inc.
• CathWorks
• Circle Cardiovascular Imaging Inc.
• General Electric Company
• HeartFlow, Inc.
• iRhythm Technologies, Inc.
• Koninklijke Philips NV

第 16 章：策略建議

第17章調查會社について,免責事項

The Global Cardiac AI Monitoring and Diagnostics Market was valued at USD 1.24 billion in 2024 and is projected to reach USD 2.11 billion by 2030, growing at a CAGR of 9.42%. This market is experiencing rapid evolution, driven by the rising burden of cardiovascular diseases and the growing demand for advanced diagnostic technologies. Artificial intelligence (AI) is increasingly being integrated into cardiac care, enabling early and accurate detection of heart conditions through advanced analysis of ECGs, cardiac imaging, and biomarker data. These AI tools support early intervention, reduce diagnostic errors, and improve patient outcomes. As remote monitoring and telemedicine adoption accelerate, AI-powered wearable devices are becoming more prevalent, offering real-time insights into heart health and personalized care. The expansion of cloud infrastructure, data integration capabilities, and continuous learning algorithms is further fueling innovation across the ecosystem. The market is set for robust growth, with healthcare providers and technology companies collaborating to deliver scalable, precise, and accessible cardiac diagnostics.

Key Market Drivers

Rise in Cardiovascular Diseases

The increasing global prevalence of cardiovascular diseases (CVDs) is a key driver of the Cardiac AI Monitoring and Diagnostics Market. Responsible for approximately 17.9 million deaths annually, CVDs remain the leading cause of mortality worldwide. Early detection and timely management are crucial, yet traditional methods often fail to identify asymptomatic or early-stage cardiac issues. AI-driven diagnostic tools offer enhanced accuracy by analyzing vast datasets-including ECGs, imaging, and lab results-to detect subtle indicators of disease. A 2024 study in The Lancet Digital Health reported over 90% diagnostic accuracy in identifying asymptomatic left ventricular dysfunction using AI-enhanced ECGs. This advanced capability allows clinicians to intervene earlier, improving patient outcomes and reducing healthcare burdens. As awareness grows and healthcare systems prioritize proactive management of heart disease, AI-enabled diagnostics are becoming an essential part of modern cardiology.

Key Market Challenges

Data Availability and Quality

One of the major challenges facing the Cardiac AI Monitoring and Diagnostics Market is the variability and fragmentation of cardiac health data. Data is sourced from diverse systems such as wearables, electronic health records, imaging tools, and clinical sensors, which often lack interoperability. This inconsistency hinders seamless integration and limits the formation of comprehensive datasets needed for effective AI model training. In addition, annotated or labeled cardiac datasets are often scarce, as producing them requires labor-intensive manual review by experts. Bias in data collection-due to uneven representation of demographics or conditions-can also affect model performance, leading to unreliable results or unequal care outcomes. Without standardization and centralized data sharing frameworks, the pace of AI development and deployment in cardiac diagnostics may be slowed, limiting the market's full potential.

Key Market Trends

Rise of Wearable and Remote Monitoring

The growing adoption of AI-powered wearable devices is transforming the way cardiac conditions are monitored and managed. These devices continuously track heart activity, gather vital data, and provide real-time feedback to patients and clinicians, enabling proactive care. Personalized cardiac care is also emerging as a key trend, with AI analyzing patient-specific data-such as genetics, lifestyle, and physiological indicators-to customize treatment strategies. AI is increasingly being applied to interpret ECGs, echocardiograms, and other imaging tools, aiding in the early detection of subtle cardiac anomalies. Additionally, AI is streamlining clinical trials by improving patient selection and predicting therapeutic outcomes. The widespread adoption of telemedicine following the COVID-19 pandemic has further propelled interest in AI-enabled diagnostic tools that support remote consultations. As these algorithms evolve with continuous learning from real-world data, their diagnostic precision and clinical utility are expected to increase, driving greater integration into standard cardiac care pathways.

Key Market Players

• AliveCor Inc.
• Aidoc
• Boston Scientific Corporation
• Canon Inc.
• CathWorks
• Circle Cardiovascular Imaging Inc.
• General Electric Company
• HeartFlow, Inc.
• iRhythm Technologies, Inc.
• Koninklijke Philips N.V.

Report Scope:

In this report, the Global Cardiac AI Monitoring and Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiac AI Monitoring and Diagnostics Market, By Product:

• Software
• Hardware

Cardiac AI Monitoring and Diagnostics Market, By Type:

• Cardiac Diagnostics (Imaging, ECG-Based, Others)
• Cardiac Monitoring

Cardiac AI Monitoring and Diagnostics Market, By Application:

• Ischemic Heart Disease/CAD
• Cardiac Arrhythmias
• Ischemic Stroke
• Others

Cardiac AI Monitoring and Diagnostics Market, By End User:

• Hospitals
• Diagnostic Centers
• Other

Cardiac AI Monitoring and Diagnostics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiac AI Monitoring and Diagnostics Market.

Available Customizations:

Global Cardiac AI Monitoring and Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cardiac AI Monitoring and Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Software, Hardware)
  • 5.2.2. By Type (Cardiac Diagnostics {Imaging, ECG-Based, Others}, Cardiac Monitoring)
  • 5.2.3. By Application (Ischemic Heart Disease/CAD, Cardiac Arrhythmias, Ischemic Stroke, Others)
  • 5.2.4. By End User (Hospitals, Diagnostics Centers, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Cardiac AI Monitoring and Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cardiac AI Monitoring and Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Cardiac AI Monitoring and Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Cardiac AI Monitoring and Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Cardiac AI Monitoring and Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cardiac AI Monitoring and Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Cardiac AI Monitoring and Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Cardiac AI Monitoring and Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Cardiac AI Monitoring and Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End-User
  • 7.3.5. Spain Cardiac AI Monitoring and Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End-User

8. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cardiac AI Monitoring and Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Cardiac AI Monitoring and Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Cardiac AI Monitoring and Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Cardiac AI Monitoring and Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Cardiac AI Monitoring and Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Cardiac AI Monitoring and Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cardiac AI Monitoring and Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Cardiac AI Monitoring and Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Cardiac AI Monitoring and Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Cardiac AI Monitoring and Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cardiac AI Monitoring and Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Cardiac AI Monitoring and Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Cardiac AI Monitoring and Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. AliveCor Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Aidoc
• 15.3. Boston Scientific Corporation
• 15.4. Canon Inc.
• 15.5. CathWorks
• 15.6. Circle Cardiovascular Imaging Inc.
• 15.7. General Electric Company
• 15.8. HeartFlow, Inc.
• 15.9. iRhythm Technologies, Inc.
• 15.10. Koninklijke Philips N.V.

16. Strategic Recommendations

17. About Us & Disclaimer